Comparative Incidence of Postoperative Hemorrhage in Vitreoretinal Surgery in Patients on Anti-Coagulants

BACKGROUND AND OBJECTIVE: Data regarding hemorrhagic complications of direct oral anticoagulants (DOACs) and vitreoretinal surgery are limited

Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging retina. - 2013. - 52(2021), 7 vom: 24. Juli, Seite 374-379
1. Verfasser: Starr, Matthew R (VerfasserIn)
Weitere Verfasser: Ammar, Michael J, Patel, Luv G, Boucher, Nicholas, Yonekawa, Yoshihiro, Garg, Sunir J, Hsu, Jason, Ho, Allen C, Regillo, Carl D, Chiang, Allen
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Ophthalmic surgery, lasers & imaging retina
Schlagworte:Journal Article Multicenter Study
LEADER 01000naa a22002652 4500
001 NLM328542342
003 DE-627
005 20231225203143.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.3928/23258160-20210628-03  |2 doi 
028 5 2 |a pubmed24n1095.xml 
035 |a (DE-627)NLM328542342 
035 |a (NLM)34309424 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Starr, Matthew R  |e verfasserin  |4 aut 
245 1 0 |a Comparative Incidence of Postoperative Hemorrhage in Vitreoretinal Surgery in Patients on Anti-Coagulants 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 24.11.2021 
500 |a Date Revised 24.11.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a BACKGROUND AND OBJECTIVE: Data regarding hemorrhagic complications of direct oral anticoagulants (DOACs) and vitreoretinal surgery are limited 
520 |a PATIENTS AND METHODS: Multicenter analysis of longitudinal, aggregated electronic health records of patients undergoing pars plana vitrectomy (PPV) with no prior history of ocular hemorrhage. Retrospective analysis of patients undergoing PPV between January 1, 2013, and December 31, 2019. The main outcomes were development of postoperative hemorrhagic complications within 1 month following vitreoretinal surgery 
520 |a RESULTS: A total of 58,131 eyes underwent PPV, with 2,956 (5.1%) on anticoagulant medication prior to surgery. Eight hundred twenty-eight eyes (1.4%) developed a postoperative hemorrhage. Of eyes with anticoagulation use, 50 of 2,956 (1.29%) developed a hemorrhage, whereas 778 of 55,175 (1.41%) of the eyes with no prior anticoagulation use developed a postoperative hemorrhage (P = .2107) 
520 |a CONCLUSION: Use of DOACs prior to vitreoretinal surgery does not appear to be associated with increased rates of postoperative intraocular hemorrhage. [Ophthalmic Surg Lasers Imaging Retina. 2021;52:374-379.] 
650 4 |a Journal Article 
650 4 |a Multicenter Study 
700 1 |a Ammar, Michael J  |e verfasserin  |4 aut 
700 1 |a Patel, Luv G  |e verfasserin  |4 aut 
700 1 |a Boucher, Nicholas  |e verfasserin  |4 aut 
700 1 |a Yonekawa, Yoshihiro  |e verfasserin  |4 aut 
700 1 |a Garg, Sunir J  |e verfasserin  |4 aut 
700 1 |a Hsu, Jason  |e verfasserin  |4 aut 
700 1 |a Ho, Allen C  |e verfasserin  |4 aut 
700 1 |a Regillo, Carl D  |e verfasserin  |4 aut 
700 1 |a Chiang, Allen  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmic surgery, lasers & imaging retina  |d 2013  |g 52(2021), 7 vom: 24. Juli, Seite 374-379  |w (DE-627)NLM224956647  |x 2325-8179  |7 nnns 
773 1 8 |g volume:52  |g year:2021  |g number:7  |g day:24  |g month:07  |g pages:374-379 
856 4 0 |u http://dx.doi.org/10.3928/23258160-20210628-03  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_40 
912 |a GBV_ILN_63 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_90 
912 |a GBV_ILN_91 
912 |a GBV_ILN_130 
912 |a GBV_ILN_135 
912 |a GBV_ILN_136 
912 |a GBV_ILN_151 
912 |a GBV_ILN_181 
912 |a GBV_ILN_203 
912 |a GBV_ILN_217 
912 |a GBV_ILN_235 
912 |a GBV_ILN_289 
912 |a GBV_ILN_294 
912 |a GBV_ILN_297 
912 |a GBV_ILN_350 
912 |a GBV_ILN_352 
912 |a GBV_ILN_674 
912 |a GBV_ILN_676 
912 |a GBV_ILN_688 
912 |a GBV_ILN_698 
912 |a GBV_ILN_721 
912 |a GBV_ILN_737 
912 |a GBV_ILN_791 
912 |a GBV_ILN_812 
951 |a AR 
952 |d 52  |j 2021  |e 7  |b 24  |c 07  |h 374-379